BOGLE INVESTMENT MANAGEMENT L P /DE/ - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 93 filers reported holding CYTOKINETICS INC in Q1 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
BOGLE INVESTMENT MANAGEMENT L P /DE/ ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q2 2017$4,957,000
+84.8%
409,679
+96.2%
0.36%
+93.0%
Q1 2017$2,682,000
-32.1%
208,781
-44.7%
0.19%
-34.2%
Q4 2015$3,951,000
+173.0%
377,801
+74.6%
0.28%
+175.7%
Q3 2015$1,447,000
+86.7%
216,368
+87.5%
0.10%
+77.6%
Q2 2015$775,000
+258.8%
115,379
+261.1%
0.06%
+286.7%
Q1 2015$216,000
-80.8%
31,949
-90.0%
0.02%
-79.5%
Q3 2014$1,125,000
-57.4%
319,647
-42.2%
0.07%
-58.8%
Q2 2014$2,643,000
-21.4%
553,008
+56.1%
0.18%
-23.4%
Q1 2014$3,364,000
-0.6%
354,180
-20.8%
0.23%
-32.7%
Q3 2013$3,384,000447,0350.34%
Other shareholders
CYTOKINETICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
BVF INC/IL 5,721,888$41,198,0004.18%
Virtus ETF Advisers LLC 93,309$672,0000.58%
IRONWOOD INVESTMENT MANAGEMENT LLC 105,324$758,0000.55%
LANSDOWNE PARTNERS (UK) LLP 2,647,981$19,065,0000.20%
WASATCH ADVISORS LP 1,761,882$12,686,0000.16%
PINNACLE ASSOCIATES LTD 888,415$6,397,0000.12%
ESSEX INVESTMENT MANAGEMENT CO LLC 84,690$610,0000.08%
Birchview Capital, LP 10,000$72,0000.05%
Piermont Capital Management Inc. 16,530$119,0000.04%
Tekla Capital Management LLC 137,797$992,0000.04%
View complete list of CYTOKINETICS INC shareholders